Cargando…
Stenotrophomonas maltophilia resistant to trimethoprim – sulfamethoxazole: an increasing problem
Stenotrophomonas maltophilia (S. maltophilia) has recently emerged as an important nosocomial pathogen. Treatment of invasive infections caused by this organism is difficult as the bacterium is frequently resistant to a wide range of commonly used antimicrobials. Trimethoprim-sulfamethoxazole (TMP –...
Autor principal: | Al-Jasser, Asma Marzouq |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1578578/ https://www.ncbi.nlm.nih.gov/pubmed/16978420 http://dx.doi.org/10.1186/1476-0711-5-23 |
Ejemplares similares
-
Osteomyelitis due to Stenotrophomonas maltophilia treated with trimethoprim-sulfamethoxazole monotherapy
por: Osakwe, Nonso
Publicado: (2023) -
Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China
por: Hu, Li-Fen, et al.
Publicado: (2016) -
The sul1 Gene in Stenotrophomonas maltophilia With High-Level Resistance to Trimethoprim/Sulfamethoxazole
por: Chung, Hae-Sun, et al.
Publicado: (2015) -
Clinical and microbiological characteristics of patients colonized or
infected by Stenotrophomonas maltophilia: is resistance to
sulfamethoxazole/trimethoprim a problem?
por: Mendes, Elisa Teixeira, et al.
Publicado: (2020) -
Global Emergence of Trimethoprim/Sulfamethoxazole Resistance in Stenotrophomonas maltophilia Mediated by Acquisition of sul Genes
por: Toleman, Mark A., et al.
Publicado: (2007)